Staging therapy in HCM patients with heart failure: New insights

EBAC-accredited Satellite Symposium during Heart Failure 2024, Lisbon, Portugal & Online

Live Meeting
0.75 available credits
Information
May 11, 2024
09:45 - 10:30 WEST
Centro de Congressos de Lisboa
Praça de Indústrias, 1300-307 Lisbon, PT, Lecture room 2, Lisbon, Portugal
Details
Presenters
Comments
  • Overview

    Invitation to the EBAC-accredited satellite symposium 'Staging therapy in HCM patients with heart failure: New insights', at ESC HF 2024, Lisbon, Portugal.

    For more information, please visit the ESC website.

    Learning Objectives

    Educational Objectives

    • Identify patient presentations that provide an entry point to use an HCM-specific therapeutic approach
    • Analyze the latest clinical data regarding the use of myosin inhibitors in the treatment of HCM in patients with heart failure
    • Discuss the evidence supporting and recommendations of recently published guidelines on HCM

    Agenda

    Chair: Petar Seferović, MD, PhD - Belgrade, Serbia

    09:45 – 09:50  Welcome and introduction - Petar Seferović, MD, PhD - Belgrade, Serbia

    09:50 – 10:00  Recognition and diagnosing heart failure in patients with HCM - Aleš Linhart, MD, PhD - Prague, Czech Republic

    10:00– 10:10   Optimal pharmacological management of HCM by clinical manifestations - Pablo García-Pavía, MD, PhD - Madrid, Spain

    10:10 – 10:20  Evidence-based novel therapies in HCM - Michelle Michels, MD, PhD - Rotterdam, The Netherlands

    10:20 – 10:30  Panel discussion and Q&A - All faculty 

    CME Accreditation

    This program is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC)  for 1 hour of external CME credit(s). Each participant should claim only those hours of credit that have actually been spent in the educational activity. The Accreditation Council for Continuing Medical Education (ACCME®) and EBAC have recognized each other’s accreditation systems as substantially equivalent.

    Funding

    This symposium is supported by an unrestricted educational grant from Bristol Myers Squibb.

  • System Requirements

    • Supported Browsers (2 most recent versions):
      • Google Chrome for Windows, Mac OS, iOS, and Android
      • Apple Safari for Mac OS and iOS
      • Mozilla Firefox for Windows, Mac OS, iOS, and Android
      • Microsoft Edge for Windows
    • Recommended Internet Speed: 5Mbps+

Facebook Comments

Details
Presenters
Comments
  • Overview

    Invitation to the EBAC-accredited satellite symposium 'Staging therapy in HCM patients with heart failure: New insights', at ESC HF 2024, Lisbon, Portugal.

    For more information, please visit the ESC website.

    Learning Objectives

    Educational Objectives

    • Identify patient presentations that provide an entry point to use an HCM-specific therapeutic approach
    • Analyze the latest clinical data regarding the use of myosin inhibitors in the treatment of HCM in patients with heart failure
    • Discuss the evidence supporting and recommendations of recently published guidelines on HCM

    Agenda

    Chair: Petar Seferović, MD, PhD - Belgrade, Serbia

    09:45 – 09:50  Welcome and introduction - Petar Seferović, MD, PhD - Belgrade, Serbia

    09:50 – 10:00  Recognition and diagnosing heart failure in patients with HCM - Aleš Linhart, MD, PhD - Prague, Czech Republic

    10:00– 10:10   Optimal pharmacological management of HCM by clinical manifestations - Pablo García-Pavía, MD, PhD - Madrid, Spain

    10:10 – 10:20  Evidence-based novel therapies in HCM - Michelle Michels, MD, PhD - Rotterdam, The Netherlands

    10:20 – 10:30  Panel discussion and Q&A - All faculty 

    CME Accreditation

    This program is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC)  for 1 hour of external CME credit(s). Each participant should claim only those hours of credit that have actually been spent in the educational activity. The Accreditation Council for Continuing Medical Education (ACCME®) and EBAC have recognized each other’s accreditation systems as substantially equivalent.

    Funding

    This symposium is supported by an unrestricted educational grant from Bristol Myers Squibb.

  • System Requirements

    • Supported Browsers (2 most recent versions):
      • Google Chrome for Windows, Mac OS, iOS, and Android
      • Apple Safari for Mac OS and iOS
      • Mozilla Firefox for Windows, Mac OS, iOS, and Android
      • Microsoft Edge for Windows
    • Recommended Internet Speed: 5Mbps+

Facebook Comments

Register

We’re glad to see you’re enjoying PACE-CME…
but how about a more personalized experience?

Register for free